Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.16.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JQ.2.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used